---
title: "Researchers Identify Protein MTCH2 Role in Obesity Treatment"
url: https://noti.group/researchers-identify-protein-mtch2-role-in-obesity-treatment/
language: en
publisher: "Noti Group"
section: "Health"
published: 2026-10-24T11:16:08.000Z
updated: 2026-10-24T19:36:56.162Z
id: 7735f3ea-1169-4380-8deb-e6b9d827f783
source: "ScienceDaily Health https://www.sciencedaily.com/releases/2026/10/261023002905.htm"
attribution: "Link to https://noti.group/researchers-identify-protein-mtch2-role-in-obesity-treatment/ and name Noti Group when you quote or summarize this story."
---

# Researchers Identify Protein MTCH2 Role in Obesity Treatment

Scientists have discovered a protein called MTCH2 that plays a crucial role in controlling how our cells use energy, which could revolutionize the way we approach obesity treatment.

Scientists have made a groundbreaking discovery that could revolutionize the way we approach obesity treatment. Researchers at the Weizmann Institute of Science have identified a protein called MTCH2, which plays a crucial role in controlling how our cells use energy.

When this protein is disabled, cells begin to consume more fuel, including fats and carbohydrates, leading to increased fat consumption and reduced formation of new fat cells. This discovery raises the possibility of a new approach to treating obesity that doesn't involve suppressing appetite.

The researchers' findings are based on laboratory experiments where they disabled MTCH2 in cells. The results showed that without this protein, cells burn more energy and reduce their ability to store fat. This could have significant implications for obesity treatment.

The study builds on earlier research conducted in mice, which found that switching off MTCH2 in muscle tissue increased energy expenditure, improved endurance, and protected the animals from diet-related obesity.

These findings were published in The EMBO Journal in January 2025 and suggest that manipulating MTCH2 could offer a way to influence both fat burning and fat accumulation. Further research has provided additional evidence of its importance in regulating body fat and metabolism.

While medications designed to promote weight loss have been effective, they often come with unwanted side effects. Many patients who lose weight experience a decline in lean body mass, which is essential for strength, mobility, and metabolic health.

The focus on MTCH2 offers a new direction for obesity treatment, one that targets the underlying mechanisms of fat storage rather than just suppressing appetite. This could lead to more effective and sustainable weight loss solutions.

Researchers have been investigating ways to reduce body fat while preserving muscle mass, essential for long-term health.

A key discovery has been made in understanding how weight loss affects lean tissue, revealing that it accounts for a significant proportion of weight lost with various weight-loss medications and lifestyle interventions.

Adding resistance training to these interventions helps preserve even more lean tissue, highlighting the importance of incorporating strength-building exercises into weight loss regimens.

Scientists have identified a protein called MTCH2 as a potential target in the fight against obesity. By reducing its activity in mice, researchers observed striking effects on their metabolism and body composition.

The genetically modified animals showed increased metabolic activity, were resistant to diet-induced obesity, and experienced favorable changes in overall body composition.

In addition to resisting excess fat accumulation, these mice also performed better in exercise and stress tests, with improvements in heart function. Their muscles developed more fibers capable of using oxygen efficiently, enhancing physical endurance.

This finding has sparked interest in the role that MTCH2 plays in influencing energy use, fat storage, and physical activity.

Mitochondria are dynamic structures that constantly change shape and form networks or separate into smaller units. This process is crucial for coordinating energy production within cells. When mitochondria fuse, they create interconnected systems that help cells produce and consume energy efficiently.

However, if the protein responsible for mitochondrial fusion, known as Mitch, is absent, the mitochondrial network becomes fragmented. As a result, cells experience changes in energy efficiency and demand, forcing them to consume more fuel to meet their needs.

This phenomenon was observed in mice that lacked the MTCH2 gene, which encodes the protein Mitch. Their cells were operating in an energy-intensive state, leading to unusual metabolism patterns. The question remained whether disabling Mitch would have a similar effect on human cells.

To answer this, researchers used genetic engineering to remove MTCH2 from human cells grown in the laboratory. This disrupted the normal structure of their mitochondrial networks, causing individual mitochondria to become more separated.

The balance between energy production and demand shifted as a result, leading to a persistent shortage of readily available energy relative to the cells' needs. To compensate for this deficit, the cells began consuming more nutrients, including oxygen.

As part of the experiment, researchers monitored over 100 substances involved in metabolism within human cells. They found that deleting Mitch led to an increase in cellular respiration, the process by which cells extract usable energy from nutrients.

This increased activity requires a greater supply of fuel, typically resulting in the consumption of more carbohydrates and fats. The findings suggest that disabling MTCH2 has a significant impact on how human cells produce and consume energy.

Cells lacking MTCH2 consumed more of every essential nutrient, including fats, carbohydrates, and amino acids, which are the building blocks of proteins.

The study found that cells without MTCH2 relied less on their usual mix of energy sources and instead increased their use of fatty acids for fuel.

Researchers observed a significant shift in how these altered cells utilized nutrients to meet their energy demands, indicating that MTCH2 plays a crucial role not only in the amount of energy consumed but also in determining which nutrients are used as fuel.

The discovery revealed a major drop in fats present in cell membranes, while an increase was seen in fatty substances used for energy production. This suggested that the fat stored in membranes is broken down to be used as fuel when MTCH2 is absent.

Cell membranes, composed mainly of fatty molecules called lipids, protect cells and facilitate many essential functions by regulating the flow of nutrients and waste products.

Cells without MTCH2 seemed to alter how they distributed and utilized these lipids, drawing on their available fatty resources to support increased energy consumption. This change was not merely a result of eliminating cellular fat but had more complex implications.

Detailed analysis also showed changes in stored lipids, indicating that the effect was more intricate than initially thought, with MTCH2 regulating how cells allocate nutrients between energy production and other biological needs.

The researchers then investigated whether MTCH2 influences the development of new fat cells. This inquiry was particularly relevant given previous studies showing elevated levels of MTCH2 in fat tissue from women with obesity.

The process of creating and storing fat requires significant energy and resources. To this end, cells must be able to consume and metabolize nutrients efficiently while also developing the necessary components for fat storage.

Gross's team hypothesized that removing MTCH2 would disrupt this delicate balance by forcing cells to prioritize fuel consumption over fat synthesis. This idea was tested in experiments using mouse precursor fat cells.

The results of these experiments were striking, with a significant reduction in the number of cells able to mature into fully formed fat cells when MTCH2 was deleted. Approximately 80-90% of normal precursor cells differentiated within six days, compared to just 5-10% of cells lacking MTCH2.

Cells without MTCH2 also accumulated substantially fewer lipid droplets, which are essential for storing fat. This finding suggests that the absence of MTCH2 not only hampers fat storage but also disrupts the cellular machinery necessary for new fat-storing cells to develop.

The team's observations indicate that disabling MTCH2 has a dual impact on fat metabolism. On one hand, it increases the consumption of energy-rich nutrients, while on the other, it interferes with the cellular processes required for developing new fat-storing cells.

These findings were obtained using both mouse-derived cell lines and human cells, providing evidence of a broader role for MTCH2 in regulating nutrient consumption and fat storage. However, more research is needed to determine whether blocking this protein would be effective in preventing new fat cells from forming in people.

Research has continued to shed light on the role of MTCH2 in regulating metabolism, particularly in relation to energy expenditure and fat storage. The findings were published in a recent study that built upon earlier research.

An international team of scientists analyzed human and mouse fat samples, studied cultured fat cells, and conducted experiments with genetically modified mice to further understand how MTCH2 influences metabolic processes. Their investigation revealed another mechanism by which this protein contributes to energy expenditure in fat tissue.

The researchers found that MTCH2 plays a role in regulating the movement of fatty acids into mitochondria, where they can be broken down to produce energy. This process involves an enzyme called carnitine palmitoyltransferase 1, or CPT1, which acts as a checkpoint for determining how much fat can enter mitochondria.

CPT1 activity is normally regulated by malonyl-CoA, a molecule that signals when cells should limit fatty acid consumption. However, the study discovered that MTCH2 physically interacts with CPT1 and influences the regulatory signal's effect on the enzyme.

The removal of MTCH2 in mice led to an increase in mitochondrial fatty acid utilization and energy expenditure without any corresponding reduction in food intake, providing further insight into why disabling this protein could encourage fat burning.

---
Source: [ScienceDaily Health](https://www.sciencedaily.com/releases/2026/10/261023002905.htm)  
Published by Noti Group: https://noti.group/researchers-identify-protein-mtch2-role-in-obesity-treatment/
